The board of directors of Nasdaq-listed company Anixa Biosciences has approved the purchase of Bitcoin as a reserve asset
ChainCatcher news, according to PR Newswire, the NASDAQ-listed company Anixa Biosciences, Inc. (NASDAQ: ANIX) announced that its board has approved the purchase of Bitcoin as a treasury reserve asset, aimed at diversifying the company's assets while allowing Anixa to benefit from the potential long-term value of digital assets.
It is reported that Anixa is a clinical-stage biotechnology company focused on cancer treatment and prevention.
Related tags
ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click "Report", and we will handle it promptly.
Related tags